Real-world treatment of pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia using tisagenlecleucel that is out of specification for commercial release Meeting Abstract
| Authors: | Rossoff, J.; Baggott, C.; Prabhu, S.; Pacenta, H.; Phillips, C. L.; Stefanski, H.; Talano, J. A.; Moskop, A.; Margossian, S. P.; Verneris, M. R.; Myers, G. D.; Karras, N.; Brown, P. A.; Qayed, M.; Hermiston, M.; Satwani, P.; Krupski, C.; Keating, A.; Wilcox, R.; Rabik, C. A.; Fabrizio, V.; Kunicki, M.; Chinnabhandar, V.; Goksenin, A. Y.; Curran, K. J.; Mackall, C. L.; Laetsch, T. W.; Schultz, L. M. |
| Abstract Title: | Real-world treatment of pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia using tisagenlecleucel that is out of specification for commercial release |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607205603182 |
| DOI: | 10.1182/blood-2020-136674 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 42 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
